For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating ...

Dr. Tom Keenan is an award-winning journalist, public speaker, professor in the School of Architecture, Planning and ...

Researchers Discover a Mechanism That Impairs Synaptic Plasticity in the Brains of Schizophrenia Patients Sep. 4, 2024 — A study mapped genes linked to schizophrenia and uncovered a mechanism ...

Researchers have developed a potential diagnostic tool for schizophrenia by observing how patients process conflicting information.

It is relevant to recognize that a number of factors may have made it difficult for clinicians and investigators to recognize panic syndromes in patients with schizophrenia. Diagnostic ...

This study explored the agreement or discrepancy between subjective difficulties in social cognition and actual cognitive ...

"Our goal was to derive a biomarker for executive dysfunction in schizophrenia, which only emerged when patients were taxed ...

There’s evidence that CBT — a type of psychotherapy, or talk therapy — may help some people with avolition in schizophrenia. “Many patients with avolition also have what we call ...

Patients with schizophrenia have a lot of life-changing consequences when they are being treated properly, and these are only amplified when the patient goes untreated, explained Megan Ehret ...

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the ...

Cobenfy (xanomeline/trospium chloride; formerly KarXT) was approved for schizophrenia in adults by the Food and Drug Administration in late September. The drug has a novel mechanism of action ...

Auditory verbal hallucinations are one of the hallmarks of psychosis, particularly in people with schizophrenia, which affects 24 million people globally. These voices often bully or abuse the ...